Capital International Sarl’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.3M Buy
94,516
+6,630
+8% +$2.36M 0.54% 48
2025
Q4
$28.8M Sell
87,886
-37,234
-30% -$11.8M 0.46% 56
2025
Q3
$35.3M Buy
125,120
+46,052
+58% +$13.4M 0.61% 48
2025
Q2
$22.1M Buy
79,068
+9,116
+13% +$2.58M 0.42% 66
2025
Q1
$21.8M Buy
69,952
+59,026
+540% +$17.4M 0.49% 59
2024
Q4
$2.85M Buy
10,926
+7,071
+183% +$2.1M 0.07% 158
2024
Q3
$1.24M Sell
3,855
-705
-15% -$231K 0.03% 206
2024
Q2
$1.42M Buy
+4,560
New +$1.34M 0.04% 191
2022
Q1
Sell
-11,271
Closed -$2.54M 259
2021
Q4
$2.54M Buy
11,271
+1,554
+16% +$328K 0.12% 170
2021
Q3
$2.07M Buy
+9,717
New +$2.24M 0.18% 137

Other funds holding AMGN

Capital International Sarl's AMGN Position: Q1 2026 in Review

Capital International Sarl increased its Amgen (AMGN) stake by 7.5% in Q1 2026, buying an estimated $2.36M and bringing the position to 94,516 shares worth $33.3M. The position accounts for 0.54% of the portfolio, ranked #48.

Capital International Sarl first reported a position in AMGN in Q3 2021 and has held it in 10 quarters since. The position peaked at $35.3M in Q3 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital International Sarl held 94,516 shares of Amgen worth $33.3M as of Q1 2026.
  • Capital International Sarl bought 6,630 Amgen shares in Q1 2026, an estimated $2.36M.
  • Amgen made up 0.54% of Capital International Sarl's portfolio in Q1 2026, its #48 holding.
  • Capital International Sarl first reported a position in Amgen in Q3 2021 and has held it in 10 quarters since.
  • Capital International Sarl's Amgen position peaked at $35.3M in Q3 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.